Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Nature Medicine
|
January 28, 2026
Publisher Correction: argeting of HIF2-driven cachexia in kidney cancer
Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Biorxiv : the Preprint Server for Biology
|
September 18, 2025
HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 Inhibitors
Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Medicine
|
November 29, 2025
Targeting of HIF2-driven cachexia in kidney cancer
Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Scientific Reports
|
October 30, 2021
Patient-derived organoids as a platform for modeling a patient's response to chemoradiotherapy in esophageal cancer
Tatiana A Karakasheva, Joel T Gabre, Uma M Sachdeva, et al.
Genes & Development
|
August 3, 2018
The LIN28B-IMP1 post-transcriptional regulon has opposing effects on oncogenic signaling in the intestine
Priya Chatterji, Kathryn E Hamilton, Shun Liang, et al.
Science Translational Medicine
|
August 28, 2024
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer
Loretah Chibaya, Kelly D DeMarco, Christina F Lusi, et al.
Cancer Discovery
|
February 16, 2021
PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability
Jason R Pitarresi, Robert J Norgard, Anna M Chiarella, et al.
Developmental Cell
|
June 20, 2018
Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer
Maximilian Reichert, Basil Bakir, Leticia Moreira, et al.
Cancer Research
|
March 12, 2024
A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer
Brooke A Brown, Paul J Myers, Sara J Adair, et al.
Nature Communications
|
July 22, 2024
Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8<sup>+</sup> T cell activation and limit responsiveness to immunotherapy in mice
Benjamin Assouline, Rachel Kahn, Lutfi Hodali, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Nature Medicine
|
January 28, 2026
Publisher Correction: argeting of HIF2-driven cachexia in kidney cancer
Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Biorxiv : the Preprint Server for Biology
|
September 18, 2025
HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 Inhibitors
Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Medicine
|
November 29, 2025
Targeting of HIF2-driven cachexia in kidney cancer
Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Scientific Reports
|
October 30, 2021
Patient-derived organoids as a platform for modeling a patient's response to chemoradiotherapy in esophageal cancer
Tatiana A Karakasheva, Joel T Gabre, Uma M Sachdeva, et al.
Genes & Development
|
August 3, 2018
The LIN28B-IMP1 post-transcriptional regulon has opposing effects on oncogenic signaling in the intestine
Priya Chatterji, Kathryn E Hamilton, Shun Liang, et al.
Science Translational Medicine
|
August 28, 2024
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer
Loretah Chibaya, Kelly D DeMarco, Christina F Lusi, et al.
Cancer Discovery
|
February 16, 2021
PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability
Jason R Pitarresi, Robert J Norgard, Anna M Chiarella, et al.
Developmental Cell
|
June 20, 2018
Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer
Maximilian Reichert, Basil Bakir, Leticia Moreira, et al.
Cancer Research
|
March 12, 2024
A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer
Brooke A Brown, Paul J Myers, Sara J Adair, et al.
Nature Communications
|
July 22, 2024
Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8<sup>+</sup> T cell activation and limit responsiveness to immunotherapy in mice
Benjamin Assouline, Rachel Kahn, Lutfi Hodali, et al.
Page
of 6